RENAISSANCE TECHNOLOGIES LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1037389 NEW YORK, NY

Position in INO

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,120,171

+$157,666 QoQ

Shares Held

643,777

+16.4% QoQ

Ownership

0.782%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,464,545,054 across 328 Biotechnology names. INO ranks #182 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,120,171	643,777	+16.4%	Shares	Sole	2026-05-14
2025-12-31	$962,505	553,164	-32.2%	Shares	Sole	2026-02-12
2025-09-30	$1,910,233	816,339	+148.8%	Shares	Sole	2025-11-13
2025-06-30	$669,383	328,129	+616.0%	Shares	Sole	2025-08-13
2025-03-31	$74,699	45,828	-81.1%	Shares	Sole	2025-05-14
2024-12-31	$443,418	242,305	-26.8%	Shares	Sole	2025-02-13
2024-09-30	$1,913,561	331,066	-19.4%	Shares	Sole	2024-11-13
2024-06-30	$3,317,373	410,566	-8.8%	Shares	Sole	2024-08-09
2024-03-31	$6,249,692	450,266	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.